摘要
新型冠状病毒(简称新冠病毒)奥密克戎(Omicron)变异株感染在特定人群中可引发严重危害并危及生命。Omicron变异株感染可导致进展迅速的系统性炎症反应、凝血功能异常及多器官功能损伤等病理生理改变,提示其危重症病例的临床治疗与新冠病毒其他毒株所致疾病有所不同。国家重大公共卫生事件医学中心组织感染科、呼吸科、重症医学科、儿科和发热门诊科等专家,基于目前的循证医学证据及大量临床实践,撰写本快速指引,以期规范、有效提升新冠病毒Omicron变异株感染的临床救治能力。
Novel coronavirus Omicron variant infection can cause severe illness and even death in certain populations.Omicron variant infection may lead to systemic inflammatory response,coagulation disorder,multi-organ dysfunction and other pathophysiological changes,which are different from other Novel coronavirus variants to a certain extent,so therapeutic strategies should not be the same.The National Medical Center for Major Public Health Events invited experts in fields of infectious diseases,respiratory medicine,intensive care,pediatrics and fever clinic to develop this quick guideline based on the current best evidence and extensive clinical practices.This quick guideline aims to standardize the diagnosis and treatment of novel coronavirus Omicron infection,and to improve the disease management abilities of clinicians.
作者
陈广
陈韬
舒赛男
王晓晶
马科
吴迪
王洪武
刘艳
郭威
韩梅芳
宋建新
刘铜林
李树生
赵建平
黄元成
熊勇
龚作炯
童巧霞
廖家智
方峰
罗小平
宁琴
Chen Guang;Chen Tao;Shu Sainan;Wang Xiaojing;Ma Ke;Wu Di;Wang Hongwu;Liu Yan;Guo Wei;Han Meifang;Song Jianxin;Liu Tonglin;Li Shusheng;Zhao Jianping;Huang Yuancheng;Xiong Yong;Gong Zuojiong;Tong Qiaoxia;Liao Jiazhi;Fang Feng;Luo Xiaoping;Ning Qin(National Medical Center for Major Public Health Events,Wuhan 430030,China;Department of Infectious Diseases,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Fever Clinic,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Pediatrics,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Intensive Care Unit,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Respiratory Medicine,Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China;Department of Infectious Diseases,Zhongnan Hospital of Wuhan University,Wuhan 430071,China;Department of Infectious Diseases,Renmin Hospital of Wuhan University,Wuhan 430060,China;Department of Infectious Diseases,Union Hospital of Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430022,China;Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology,Wuhan 430030,China)
出处
《中华临床感染病杂志》
CAS
CSCD
2023年第1期26-32,共7页
Chinese Journal of Clinical Infectious Diseases
基金
国家重点研发计划(2021YFC2600200)。